Pharmacists in Avondale, LA Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Dr. Alisha Blue-patterson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 Highway 90 W, Avondale, LA 70094 Phone: 504-436-7555 Fax: 504-436-9256 |
Dr. Michelle Doucette, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Highway 90 W, Avondale, LA 70094 Phone: 504-437-0650 Fax: 504-437-0541 |
Hong Tran Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 173 June Dr., Avondale, LA 70094 Phone: 504-957-7788 |
 Mr. Lawrence Jackson Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3700 Devereaux Ct, Avondale, LA 70094 Phone: 504-644-4975 |
Ms. Monica Dominique Gooden, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Highway 90 W, Avondale, LA 70094 Phone: 504-437-0650 |
Ms. Michelle Harris, P.P Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 Layman St, Avondale, LA 70094 Phone: 504-437-0632 |
Jimmie Wayne Plumer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Highway 90 W, Avondale, LA 70094 Phone: 504-437-0650 Fax: 504-437-0541 |
News Archive
Lenalidomide and SNS01-T combination effective against multiple myeloma
Senesco Technologies, Inc. announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was achieved with a combination of SNS01-T and lenalidomide.
Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.
Teva launches generic Avalide and Avapro Tablets
Teva Pharmaceutical Industries Ltd. announced today that it has commenced commercial launch of both Irbesartan and Irbesartan-Hydrochlorothiazide Tablets, the Company's generic versions of Sanofi Aventis' high blood pressure treatments, Avapro and Avalide Tablets.
PharmaEssentia to present results of P1101 + ribavirin phase II trial in HCV patients at APASL 2016
PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).
› Verified 8 days ago